SCANDINAVCHEMOTECH Ownership

8V6 Stock  EUR 0.13  0.01  8.33%   
SCANDINAVCHEMOTECH CLB shows considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in SCANDINAVCHEMOTECH CLB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

SCANDINAVCHEMOTECH Stock Ownership Analysis

About 25.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB was incorporated in 2013 and is headquartered in Lund, Sweden. SCANDINAV CHEMOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 7 people. For more info on SCANDINAVCHEMOTECH CLB please contact the company at 46 1 0218 9300 or go to http://chemotech.se.

SCANDINAVCHEMOTECH Outstanding Bonds

SCANDINAVCHEMOTECH issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SCANDINAVCHEMOTECH CLB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SCANDINAVCHEMOTECH bonds can be classified according to their maturity, which is the date when SCANDINAVCHEMOTECH CLB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in SCANDINAVCHEMOTECH Stock

SCANDINAVCHEMOTECH financial ratios help investors to determine whether SCANDINAVCHEMOTECH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCANDINAVCHEMOTECH with respect to the benefits of owning SCANDINAVCHEMOTECH security.